Show simple item record

dc.contributor.authorMahmoud, M
dc.contributor.authorEvans, I
dc.contributor.authorWisniewski, L
dc.contributor.authorTam, Y
dc.contributor.authorWalsh, C
dc.contributor.authorWalker-Samuel, S
dc.contributor.authorFrankel, P
dc.contributor.authorScambler, P
dc.contributor.authorZachary, I
dc.coverage.spatialEngland
dc.date.accessioned2022-09-12T13:30:16Z
dc.date.available2022-09-12T13:30:16Z
dc.date.issued2022-06-29
dc.identifier6322954
dc.identifier.citationCardiovascular Research, 2022, 118 (8), pp. 1993 - 2005en_US
dc.identifier.issn0008-6363
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/5438
dc.identifier.eissn1755-3245
dc.identifier.eissn1755-3245
dc.identifier.doi10.1093/cvr/cvab242
dc.description.abstractAIMS: The adapter protein p130Cas, encoded by the Bcar1 gene, is a key regulator of cell movement, adhesion, and cell cycle control in diverse cell types. Bcar1 constitutive knockout mice are embryonic lethal by embryonic days (E) 11.5-12.5, but the role of Bcar1 in embryonic development remains unclear. Here, we investigated the role of Bcar1 specifically in cardiovascular development and defined the cellular and molecular mechanisms disrupted following targeted Bcar1 deletions. METHODS AND RESULTS: We crossed Bcar1 floxed mice with Cre transgenic lines allowing for cell-specific knockout either in smooth muscle and early cardiac tissues (SM22-Cre), mature smooth muscle cells (smMHC-Cre), endothelial cells (Tie2-Cre), second heart field cells (Mef2c-Cre), or neural crest cells (NCC) (Pax3-Cre) and characterized these conditional knock outs using a combination of histological and molecular biology techniques. Conditional knockout of Bcar1 in SM22-expressing smooth muscle cells and cardiac tissues (Bcar1SM22KO) was embryonically lethal from E14.5-15.5 due to severe cardiovascular defects, including abnormal ventricular development and failure of outflow tract (OFT) septation leading to a single outflow vessel reminiscent of persistent truncus arteriosus. SM22-restricted loss of Bcar1 was associated with failure of OFT cushion cells to undergo differentiation to septal mesenchymal cells positive for SMC-specific α-actin, and disrupted expression of proteins and transcription factors involved in epithelial-to-mesenchymal transformation (EMT). Furthermore, knockout of Bcar1 specifically in NCC (Bcar1PAX3KO) recapitulated part of the OFT septation and aortic sac defects seen in the Bcar1SM22KO mutants, indicating a cell-specific requirement for Bcar1 in NCC essential for OFT septation. In contrast, conditional knockouts of Bcar1 in differentiated smooth muscle, endothelial cells, and second heart field cells survived to term and were phenotypically normal at birth and postnatally. CONCLUSION: Our work reveals a cell-specific requirement for Bcar1 in NCC, early myogenic and cardiac cells, essential for OFT septation, myocardialization and EMT/cell cycle regulation and differentiation to myogenic lineages.
dc.formatPrint
dc.format.extent1993 - 2005
dc.languageeng
dc.language.isoengen_US
dc.publisherOXFORD UNIV PRESSen_US
dc.relation.ispartofCardiovascular Research
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.subjectBcar1
dc.subjectEpithelial-to-mesenchymal transformation
dc.subjectHeart development
dc.subjectOutflow tract septation
dc.subjectAnimals
dc.subjectCrk-Associated Substrate Protein
dc.subjectEndothelial Cells
dc.subjectHeart
dc.subjectHeart Defects, Congenital
dc.subjectMice
dc.subjectMice, Knockout
dc.subjectNeural Crest
dc.subjectTranscription Factors
dc.titleBcar1/p130Cas is essential for ventricular development and neural crest cell remodelling of the cardiac outflow tract.en_US
dc.typeJournal Article
dcterms.dateAccepted2021-07-13
dc.date.updated2022-09-09T15:56:48Z
rioxxterms.versionVoRen_US
rioxxterms.versionofrecord10.1093/cvr/cvab242en_US
rioxxterms.licenseref.startdate2022-06-29
rioxxterms.typeJournal Article/Reviewen_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/34270692
pubs.issue8
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular and Systems Oncology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Cancer Stem Cell
pubs.organisational-group/ICR/Students
pubs.organisational-group/ICR/Students/PhD and MPhil
pubs.organisational-group/ICR/Students/PhD and MPhil/20/21 Starting Cohort
pubs.publication-statusPublished
pubs.publisher-urlhttp://dx.doi.org/10.1093/cvr/cvab242
pubs.volume118
icr.researchteamCancer Stem Cellen_US
icr.researchteamMol and Systems Oncologyen_US
dc.contributor.icrauthorEvans, Ian
dc.contributor.icrauthorTam, Yuen Bun
icr.provenanceDeposited by Dr Ian Evans on 2022-09-09. Deposit type is initial. No. of files: 1. Files: Bcar1p130Cas is essential for ventricular development and neural crest cell remodelling of the cardiac outflow tract.pdf


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/